$BRKR News

Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast

JP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target

TD Cowen Maintains Hold on Bruker, Raises Price Target to $62

3 Reasons BRKR is Risky and 1 Stock to Buy Instead

Why Is Bruker (BRKR) Getting Attention For Its Human Plasma Proteome Atlas?

Bruker (BRKR), Why Is Its Latest Update Drawing Fresh Attention?

Bruker Gains 66.3% in a Year: What's Driving the Rally?

Barclays Maintains Overweight on Bruker, Raises Price Target to $70

Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

Are Options Traders Betting on a Big Move in Bruker Stock?

Guggenheim Maintains Buy on Bruker, Raises Price Target to $72

Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $80

Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound

Bruker Corporation (BRKR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat?

Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley

Bruker Wins Major UC Berkeley Order For Advanced Research Systems

Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Why Bruker (BRKR) Stock Is Falling Today